Verismo Therapeutics
Elizabeth Morales has accumulated extensive work experience in the field of quality assurance and compliance within the biopharmaceutical industry. Starting as a Research Assistant at The Wistar Institute in 2009, they progressed to roles such as Associate Scientist at GSK and then moved on to quality assurance positions at WuXi AppTec, Adaptimmune, and Carisma Therapeutics. Their most recent role as Associate Director at Verismo Therapeutics showcases their expertise in quality and compliance management.
Elizabeth Morales attended Temple University where they obtained a Bachelor of Science (B.S.) degree in Biology, General.
This person is not in any offices
Verismo Therapeutics
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.